Daniel Lev, Attorney, Pierce Atwood LLP to Speak at KC’s Biotech and Diagnostic Patents Risks: What You Need to Know Live Webcast
New York, NY, April 18, 2015 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Daniel Lev, Attorney will speak at the Knowledge Congress’ webcast entitled: “Biotech and Diagnostic Patents Risks: What You Need to Know Live Webcast”. This event is scheduled for July 07, 2015 from 12:00pm – 2:00pm (ET).
For further details, please visit:
http://theknowledgegroup.org/event_name/biotech-and-diagnostic-patents-risks-what-you-need-to-know-live-webcast/
About Daniel Lev
Dan Lev focuses his practice on IP prosecution and counseling, patent litigation, and IP and technology transactions. Dan works with life science companies to develop U.S. and international patent portfolios. He counsels pharmaceutical and biotech companies regarding issues at the intersection of regulatory law and patent law. Dan regularly conducts IP due diligence and prepares non-infringement and invalidity opinions for pharmaceutical and biotech clients.
Dan has litigated patent cases before U.S. district courts and the International Trade Commission concerning diverse technologies, including biotechnology and pharmaceuticals, medical devices and diagnostics, LEDs, and semiconductors.
Dan also has extensive experience conducting and negotiating various life science transactions, including IP licenses, research and development collaborations, strategic partnerships, and joint ventures.
About Pierce Atwood LLP
There’s a reason why informed decision makers nationwide turn to Pierce Atwood LLP. The reason is not just that we deliver exceptional service and value to our clients. It’s “how” we do it. We start by attracting and retaining superb legal talent. We add to that a cost structure and a partnership system that allows us to put our clients first in all instances and to offer a reasonable rate structure including options for alternative fee arrangements, in addition to the billable hour.
By rewarding our attorneys for teamwork and collaboration, rather than “originations,” our clients get the right lawyer for the right job. Pierce Atwood is a member of The Bridge Group, a network of law firms in the United States, England, France, Belgium and Germany. The Bridge Group firms call upon each other to cover far reaching geographic areas and to address different areas of expertise in order to provide the highest level of quality and service to our clients.
We are a team of responsive, creative, collaborative and hard-working professionals who serve our clients from offices located in four New England states, the District of Columbia and Stockholm, Sweden. Pierce Atwood is the only New England-based law firm to be named to the National Law Journal’s “Midsize Hot List” four years in a row.
Our attorneys also serve in many prominent roles within the legal community including as immediate past president of the Maine Trial Lawyers Association, past president of the Boston Bar Association, former head of the American College of Trial Lawyers, and former Independent Counsel investigating allegations against the U.S. Secretary of Labor under President Clinton.
Event Synopsis:
In a two hour live Webcast, a panel of key thought leaders and professionals assembled by The Knowledge Group will provide the audience with overview of the fundamentals as well as updates of this significant topic. The speakers aims to offer the audience with the best trends and practices to avoid the common pitfalls and risk issues in Biotech and Diagnostic Patents.
Key topics include:
· Biotech and Diagnostic Patent – An Overview
· Risks and Pitfalls in Biotech and Diagnostic Patent
· Composition and Method Claims in Biotech and Diagnostic Patent
· The cDNA Sequences
· DNA Polymerization Process
· Patent Protection under 35 U.S.C. § 101
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: http://theknowledgegroup.org
For further details, please visit:
http://theknowledgegroup.org/event_name/biotech-and-diagnostic-patents-risks-what-you-need-to-know-live-webcast/
About Daniel Lev
Dan Lev focuses his practice on IP prosecution and counseling, patent litigation, and IP and technology transactions. Dan works with life science companies to develop U.S. and international patent portfolios. He counsels pharmaceutical and biotech companies regarding issues at the intersection of regulatory law and patent law. Dan regularly conducts IP due diligence and prepares non-infringement and invalidity opinions for pharmaceutical and biotech clients.
Dan has litigated patent cases before U.S. district courts and the International Trade Commission concerning diverse technologies, including biotechnology and pharmaceuticals, medical devices and diagnostics, LEDs, and semiconductors.
Dan also has extensive experience conducting and negotiating various life science transactions, including IP licenses, research and development collaborations, strategic partnerships, and joint ventures.
About Pierce Atwood LLP
There’s a reason why informed decision makers nationwide turn to Pierce Atwood LLP. The reason is not just that we deliver exceptional service and value to our clients. It’s “how” we do it. We start by attracting and retaining superb legal talent. We add to that a cost structure and a partnership system that allows us to put our clients first in all instances and to offer a reasonable rate structure including options for alternative fee arrangements, in addition to the billable hour.
By rewarding our attorneys for teamwork and collaboration, rather than “originations,” our clients get the right lawyer for the right job. Pierce Atwood is a member of The Bridge Group, a network of law firms in the United States, England, France, Belgium and Germany. The Bridge Group firms call upon each other to cover far reaching geographic areas and to address different areas of expertise in order to provide the highest level of quality and service to our clients.
We are a team of responsive, creative, collaborative and hard-working professionals who serve our clients from offices located in four New England states, the District of Columbia and Stockholm, Sweden. Pierce Atwood is the only New England-based law firm to be named to the National Law Journal’s “Midsize Hot List” four years in a row.
Our attorneys also serve in many prominent roles within the legal community including as immediate past president of the Maine Trial Lawyers Association, past president of the Boston Bar Association, former head of the American College of Trial Lawyers, and former Independent Counsel investigating allegations against the U.S. Secretary of Labor under President Clinton.
Event Synopsis:
In a two hour live Webcast, a panel of key thought leaders and professionals assembled by The Knowledge Group will provide the audience with overview of the fundamentals as well as updates of this significant topic. The speakers aims to offer the audience with the best trends and practices to avoid the common pitfalls and risk issues in Biotech and Diagnostic Patents.
Key topics include:
· Biotech and Diagnostic Patent – An Overview
· Risks and Pitfalls in Biotech and Diagnostic Patent
· Composition and Method Claims in Biotech and Diagnostic Patent
· The cDNA Sequences
· DNA Polymerization Process
· Patent Protection under 35 U.S.C. § 101
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: http://theknowledgegroup.org
Contact
The Knowledge Congress
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Categories